M61.169
Myositis ossificans progressiva, unspecified lower leg
Clinical Classification Guidelines
Medical Intelligence & Overview
Myositis ossificans progressiva (MOP) of the lower leg is a rare, progressive condition characterized by abnormal bone formation within the muscles, tendons, and other soft tissues. This condition leads to the development of ectopic bone, which can cause pain, swelling, and reduced mobility. Although it shares similarities with other types of heterotopic ossification, MOP is distinguished by its gradual progression and specific impact on the lower extremities. Patients diagnosed with this condition often experience challenges in daily activities due to joint stiffness and deformity.
Causes & Symptoms
Clinical Causes: Trauma or injury to the lower leg, such as fractures or bruises Genetic predisposition or familial history (though rare for primary MOP) Repeated or severe muscle injuries that trigger abnormal healing responses Certain medications or medical conditions that promote abnormal bone growth Unknown underlying causes in many cases, making diagnosis complex
Key Symptoms: Gradual swelling and palpable firm mass within the muscle tissue Pain or tenderness localized to affected areas Restricted movement or stiffness in the lower leg joints, especially the ankle and knee Development of hard, calcified masses that may be visible or palpable Progressive deformity and shortened muscles or tendons over time Possible skin changes over the affected region
Diagnostic & Treatment
Diagnosis Path: Medical history review, focusing on injury or trauma history Physical examination to assess swelling, firmness, and range of motion Imaging tests such as X-rays, which reveal ectopic bone formation Magnetic resonance imaging (MRI) to evaluate soft tissue involvement and rule out other pathologies Biopsy in some cases to confirm abnormal bone growth and exclude malignancies
Treatment Protocols: Rest and activity modification to minimize trauma and inflammation Physical therapy to preserve joint mobility and prevent severe contractures Medications such as non-steroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and pain Surgical removal of heterotopic bone may be considered in severe cases, especially if mobility is significantly impaired Use of radiation therapy in specific cases to inhibit abnormal bone formation Monitoring the condition regularly through imaging to assess progression
Clinical Advice & FAQs
Billing Guidance
Is M61.169 a billable ICD-10 code?
Yes, M61.169 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M61.169?
Clinical documentation must specify the nature of Myositis ossificans progressiva, unspecified lower leg and any associated comorbidities for accurate reporting.
Cite this Clinical Reference